Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy

Journal of Thoracic Oncology 2026

View at publisher
Authors: Nikhil P. Mankuzhy, Valentina Santo, Jacob Shin, Tafadzwa Lawrence Chaunzwa, Daphna Y. Gelblum, Abraham Jing-Ching Wu, Matthew T. McMillan, Jennifer Ma, David L. Billing, Puneeth Iyengar, Charles B. Simone, Michael David Offin
+11 more Adam Jacob Schoenfeld, Kathryn Cecilia Arbour, Joao M. Victor Alessi, Federica Pecci, Edoardo Garbo, Eleonora Gariazzo, Mark M. Awad, Daniel R. Gomez, Jamie E. Chaft, Biagio Ricciuti, Narek Shaverdian
DOI: 10.1016/j.jtho.2026.103565
Cited by: 1
References: 46

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Chronic Lymphocytic Leukemia Research Lung Cancer Research Studies

Publication details

Journal / source
Journal of Thoracic Oncology
Publisher
Elsevier BV
Volume
21
Issue
6
Pages
103565–103565
Publication date
1 January 2026
Language
EN